HLS Therapeutics Inc. (HLS.TO)
CAD 3.62
(0.56%)
CAD 3.62
(0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 63.07 Million | 61.46 Million | 60 Million | 56.1 Million | 54.16 Million | 61.41 Million |
| Cost of Revenue | 7.62 Million | 4.98 Million | 3.97 Million | 3.62 Million | 1.93 Million | 2.59 Million |
| Gross Profit | 55.45 Million | 56.48 Million | 56.03 Million | 52.48 Million | 52.22 Million | 58.82 Million |
| Operating Expenses | 65.79 Million | 69.98 Million | 62.32 Million | 64.57 Million | 56.85 Million | 51.18 Million |
| Selling, General and Administrative Expenses | 28.28 Million | 35.58 Million | 32.05 Million | 31.38 Million | 24.34 Million | 18.78 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 37.51 Million | 34.4 Million | 30.26 Million | 33.18 Million | 32.51 Million | 32.39 Million |
| Cost and Expenses | 73.42 Million | 74.96 Million | 66.29 Million | 68.19 Million | 58.78 Million | 53.77 Million |
| Operating Income | -10.34 Million | -13.44 Million | -6.24 Million | -11.25 Million | -4.04 Million | 7.63 Million |
| Interest Expense | 8.74 Million | 7.31 Million | 6.95 Million | 6.3 Million | 7.69 Million | 17.11 Million |
| Income Tax Expense | -272 Thousand | -124 Thousand | 1.3 Million | -968 Thousand | -911 Thousand | -3.99 Million |
| Earnings before Tax | -27.8 Million | -23.72 Million | -11.8 Million | -16.29 Million | -20.46 Million | -28.8 Million |
| Net Income | -27.53 Million | -23.59 Million | -13.11 Million | -15.33 Million | -19.55 Million | -24.8 Million |
| Earnings Per Share Basic | -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 |
| Earnings Per Share Diluted | -0.85 | -0.73 | -0.41 | -0.48 | -0.67 | -0.92 |
| Weighted Average Shares Outstanding | 32.26 Million | 32.32 Million | 32.18 Million | 31.71 Million | 29.18 Million | 26.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.26 Million | 32.43 Million | 32.18 Million | 31.71 Million | 29.36 Million | 26.95 Million |
| Gross Margin | 0.88 | 0.92 | 0.93 | 0.94 | 0.96 | 0.96 |
| EBIT Margin | 0.20 | 0.34 | 0.40 | 0.39 | 0.53 | 0.35 |
| Profit Margin | -0.44 | -0.38 | -0.22 | -0.27 | -0.36 | -0.40 |
| EBITDA | 12.88 Million | 17.99 Million | 25.41 Million | 23.19 Million | 19.74 Million | 20.7 Million |
| Earnings Before Tax Margin | -0.16 | -0.22 | -0.10 | -0.20 | -0.07 | 0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 14.51 Million | 12.47 Million | 15.86 Million | 63.07 Million | 16.03 Million | 16.41 Million |
| Cost of Revenue | 2.3 Million | 1.77 Million | 2.53 Million | 7.62 Million | 1.87 Million | 1.77 Million |
| Gross Profit | 12.21 Million | 10.69 Million | 13.33 Million | 55.45 Million | 14.16 Million | 14.64 Million |
| Operating Expenses | 14.24 Million | 14.16 Million | 14.43 Million | 65.79 Million | 17.22 Million | 17.63 Million |
| Selling, General and Administrative Expenses | 6.96 Million | 6.98 Million | 6 Million | - | 9.02 Million | 9.27 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.36 Million | - | - | - | - | -30 Thousand |
| Cost and Expenses | 16.54 Million | 15.94 Million | 16.96 Million | 73.42 Million | 19.09 Million | 19.41 Million |
| Operating Income | -2.02 Million | -3.33 Million | -893 Thousand | -9.99 Million | -2.96 Million | -2.98 Million |
| Interest Expense | 2.7 Million | 2.62 Million | 2.61 Million | 8.74 Million | 2.29 Million | 1.93 Million |
| Income Tax Expense | 4.07 Million | -29 Thousand | 75 Thousand | -272 Thousand | -424 Thousand | 117 Thousand |
| Earnings before Tax | -1.6 Million | -6.13 Million | -5.32 Million | -27.8 Million | -7.32 Million | -9.32 Million |
| Net Income | -5.68 Million | -6.1 Million | -5.4 Million | -27.53 Million | -6.9 Million | -9.43 Million |
| Earnings Per Share Basic | -0.18 | -0.19 | -0.17 | - | -0.21 | -0.29 |
| Earnings Per Share Diluted | -0.18 | -0.19 | -0.17 | - | -0.21 | -0.29 |
| Weighted Average Shares Outstanding | 31.56 Million | 31.94 Million | 31.5 Million | 32.26 Million | 32.25 Million | 32.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.56 Million | 31.94 Million | 31.77 Million | 32.26 Million | 32.25 Million | 32.34 Million |
| Gross Margin | 0.84 | 0.86 | 0.84 | 0.88 | 0.88 | 0.89 |
| EBIT Margin | 0.50 | 0.21 | 0.39 | - | 0.33 | 0.33 |
| Profit Margin | -0.39 | -0.49 | -0.34 | -0.44 | -0.43 | -0.57 |
| EBITDA | 7.28 Million | 2.58 Million | 6.15 Million | - | 5.24 Million | 5.38 Million |
| Earnings Before Tax Margin | -0.14 | -0.27 | -0.06 | -0.16 | -0.18 | -0.18 |
MAAGHADV
601377
688616
8181
NTIOF
BAS